Himalaya to build Dhs120m herbal pharma plant in Dubai

Indian pharma company Himalaya has said that it will open a Dhs120m herbal pharmaceutical plant in Dubai Industrial City.

The Himalaya Wellness facility is geared to produce three billion tablets, 15 million syrup bottles and three million units of ointment annually.

The new plant is expected to create hundreds of specialised jobs and export medicines to over 100 countries.

Commercial production is slated to start in the first quarter of 2024. The factory will be situated on a 760,000 sq. ft plot and is reported to be the first of three facilities that Himalaya will build in Dubai Industrial City.

The herbal pharmaceutical facility will subsequently be followed by dedicated units for Personal care products and Functional foods.

The plant will be built to the highest standards recognised by the World Health Organisation, the US Food and Drug Administration and the European Medicine Agency’s standards.

Himalaya entered the UAE market in 2000, and set up an R&D centre ‘Himalaya Global Research Centre’ in Dubai Science Park in 2013.

“After over 20 years of successful operations in the region, we have decided to build the manufacturing facility here for our herbal pharmaceuticals. We pride ourselves on being environment friendly and this facility would be Leeds certified – Green Building. Our flagship brands like Liv.52 & Cystone are household names in many countries and the proposed manufacturing facility will be supplying to over 100 countries,” said Shailendra Malhotra, Global CEO, Himalaya Wellness.

“The objective is to increase our global manufacturing capacity for herbal medicines, and we decided on UAE due to its strategic location, state-of-the-art infrastructure, and efficient business environment. UAE has been the cornerstone of Himalaya’s global success and this partnership with Dubai Industrial City shall further reinforce our global strategy.”